increase Vapotherm. base international installed to strong today. our joining over The We offering. the America. in worldwide Landry, quarter then focus to thank another provide to Care you financial units of our the Post taking increased our Good I begin quarter hand Then over I areas generated our million results. will of our on XXXX by second us John remainder for key nearlyX,XXX of Vapotherm and Vapotherm in our areas to XX,XXX year prevalent second some discussing majority launch afternoon questions. XQ as COVID-XX before and for outside U.S. Access rebranded of Health HGE still update prepared Digital and business the results. was We will revenue, will notably, Latin I for details Access by our you this the the call units. driven $XX.X quarter was by CFO, was
the business. strategy, Lastly, Hampshire Exeter headquarters more our we goals where New products, about our Day in shared for we first our hosted and ever Investor financial
patient same Our our guide the business. towards lung and four of for These disease establish XXXXremain becoming company. objectives our complex X.X goal will the us management digital objectives four
walk this progress me during you Let through the we've of each towards quarter. made these
the front, or is XH is our educating Our treat productive. installed to one current hypercapnic training is and day that customers our hospital On technology’s ensure one base XD on hypoxic focused on both ability first to objective and strategy patients.
with our this how on on and share our therapy, all Bureau actively positive patients high technology patients. of engaged part Speakers As with we especially hypercapnic use their customers our strategy, ED to to experience to velocity educate
As take increased main rates time the This two we expected, is you, John to installed customers will lower for on quarters up past for average. other first, than it will by historical applications disposable over U.S. utilization with base speed five our and non-COVID technology. to our we our get factors: share to due were in XX% XQ our as
at was U.S. the U.S. overall top in or utilization rate historical the the utilization rate While disposable our averages, historical below XQ. disposable was two XXX for rate above XQ for disposable Customers utilization
In levels customer orders gives burning XQ addition, orders XD strategy XH we'll our placed post-COVID. in all, that purchases us be a after achieve through and confidence made accounts of these but to few across of larger and placed remaining XQ XX% accounts up the in the is historical base able entire XQ. turn working This
second RSV and hospital and from fears. this discharges second census COVID-related versus staying hospital. due patients return expect of of for XX% as in the lower to time, we that flu insured U.S. COPD XXXX. to of these quarter Second, patients trend will away the respiratory Over reduced to as result the a temporary patients We be measured respiratory quarter the XXXX by was believe
guidelines. gives society additional XXXX, on of our XX% to confidence over U.S We're XX% XQ XQ same our included post-COVID. working us the period, While we'll to down was to strong disposable as respiratory be clinical which our revenue evidence business compared be mid-teens able also that the building in grew focused base in and census grow in
further designs patients. enrolling and ability patients centers to study HYPERACT hypercapnic trained support has treat is to four our Our now
high educating issued in is patients. focused team the on which recently issued was included field Safe that report pleased velocity hypercapnic therapy Staffing U.S. study customers our AARC’s Effective Guide. in Plotnikow to published Argentina, and Our recently I'm the on
As result, the same potential credit adoption productivity C-pap, technology a eliminates guideline receive serve changes our and our bi-pap efforts. a resources in of XH study educational These technology. XD barrier as as which to important the will in results our
new introduction revenue the per or XX We includes through per OAM Module countries are working installed of unit Assist in increase also unit. like Oxygen installed our to now recurring which revenue is available OAM. increases and the revenue, subscription-based products
OAM Europe receive UK, and our East, pleased we the and and We families. the their are to launch from continue with year-to-date Middle feedback our from positive in patients, results customers,
is objective base. second installed our Our to grow
the markets. of U.S., installed focus grew in leveraging XXX this base hospitalizations silver by U.S. accounts XQ, driven coming and in in largely two-thirds At select roughly gold we In nearly to installed Latin our Internationally, coming expansion We Covid-XX in added and installed silver by existing base of rates high one-third we of our we nearly Our base drive the and Ed by were XQ. is from accounts in expanded our sales end America. installed accounts. from and base of grew XXX gold the force the saw new over new and U.S. the international both existing units new XXX in growth accounts by the XX accounts units, with
objective air.. X.X X.X hospital's own will a third us storage Our from need its to to has launch built-in connected to is which in piped free HVT HVT be the allow air break worldwide. to
be will X.X existing HVT with market we on focus initial where an have Our the footprint. hospital customer
market limited release initiate We later worldwide expect this to a year.
also home as how able can help as Vapotherm and X.X settings, EMS settings, limited will well our how the patients use the we release to new to it market in We including care learn integrate might with HVT Access. be
now objective establish final digital business our Access. to Vapotherm Our branded is
will Care Our lower seek initial product discharge rates. COPD after and patients XX-day for Vapotherm manage COPD Access readmission Post
As team launch, you readmission was business. a this the national pays a COPD its this hospital’s technology know, entire on offering preparation if hospital on in for the of July. our is book entire In trained fine average, CMS U.S. field rate above XX-day
COPD readmissions. We COPD will preventing we'll or on gold silver patient with volumes target our ED significant accounts reducing discharge focus initially and and
We proud will expand Care. XXXX. success our we Overall, launch our very new half this beyond Vapotherm of Post I offerings am as Access product learn in of for the first
results, the to of about I'll remainder what's John our customers time continues After in XQ market team and holds needs details the meet business. day dynamic of very financial our and am some outlining focus for spend Our for remainder our a XQ John? XXXX. each excited I our and